BAYER ASPIRIN EXTRA STRENGTH (BAYER Aspirin Extra Strength Caplets)
BAYER ASPIRIN EXTRA STRENGTH risk profile, scheduling, and guidance for claims professionals and care workers . Also known as BAYER Aspirin Extra Strength Caplets.
BAYER ASPIRIN EXTRA STRENGTH (brand names: BAYER Aspirin Extra Strength Caplets) is classified as Low risk (2 risk points) by AllMeds. It is a S2 medication under the TGA in Australia. FDA approved in the United States. Higher dose aspirin increases bleeding risk and potential GI complications.
Key Takeaways
- TGA Schedule: S2 in Australia
- Risk level: Low (2 points)
- Recommended maximum duration: 10 days
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S2 | Not PBS listed |
| United States (FDA) | Rx only | FDA approved |
Risk Profile
Higher dose aspirin increases bleeding risk and potential GI complications.
Regulatory and Compliance Guidance
When BAYER ASPIRIN EXTRA STRENGTH appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as S2 under the Therapeutic Goods Administration (TGA).
United Kingdom NICE / MHRA / FPM
NICE NG59 (Low Back Pain and Sciatica) recommends considering oral NSAIDs for short-term pain management, taking into account risk factors including GI, cardiovascular, and renal risks.
United States FDA / CDC / State WC
FDA approved for use in the United States.
Need to assess this medication across your caseload?
Run a full risk assessment including BAYER ASPIRIN EXTRA STRENGTH interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.